Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STI571 (Imatinib) in Metastatic Breast Cancer
NCT00045188Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2002
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in breast cancer, sponsored by National Cancer Institute. Started Aug 2002; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00045188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045188.